AA
INFI

ALPS Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

ALPS Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-92,332
Closed -$105K – 1101
2022
Q1 		$105K Sell
92,332
-10,689
-10% -$12.8K ﹤0.01% 827
2021
Q4 		$232K Sell
103,021
-5,720
-5% -$14.4K ﹤0.01% 865
2021
Q3 		$372K Sell
108,741
-8,020
-7% -$24.7K ﹤0.01% 641
2021
Q2 		$349K Buy
+116,761
New +$369K ﹤0.01% 706
2016
Q4 		– Sell
-63,217
Closed -$99K – 739
2016
Q3 		$99K Sell
63,217
-6,246
-9% -$9.6K ﹤0.01% 670
2016
Q2 		$92K Buy
+69,463
New +$325K ﹤0.01% 604

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ALPS Advisors's INFI Position: Q2 2022 in Review

ALPS Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 92,332 shares — an estimated $105K sold.

ALPS Advisors first reported a position in INFI in Q2 2016 and held it in 6 quarters. The position peaked at $372K in Q3 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • ALPS Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • ALPS Advisors sold 92,332 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $105K.
  • ALPS Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 6 quarters.
  • ALPS Advisors's Infinity Pharmaceuticals, Inc. position peaked at $372K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.